Our physicians are global leaders in the diagnosis and multidisciplinary treatment of complex pancreatic cancer. Many of our physicians are involved in research, including clinical trials with a drug developed at the Masonic Cancer Center, University of Minnesota, for the treatment of pancreatic cancer.
Research in action
Masonic Cancer Center was one of four institutions awarded a five-year, $11.5 million grant from the National Cancer Institute to explore groundbreaking pancreatic cancer research, prevention and treatment. The grant focuses on achieving breakthroughs in research to better understand, diagnose and treat patients with pancreatic cancer. The medical center is one of a very few institutions in the country with federal funding to support a comprehensive treatment program in pancreatic cancer.